These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7853199

  • 1. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
    Raber J, Koob GF, Bloom FE.
    J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
    [Abstract] [Full Text] [Related]

  • 2. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling.
    Raber J, Bloom FE.
    J Neurosci; 1994 Oct; 14(10):6187-95. PubMed ID: 7523633
    [Abstract] [Full Text] [Related]

  • 3. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK, Rivier C.
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [Abstract] [Full Text] [Related]

  • 4. IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala.
    Raber J, Pich EM, Koob GF, Bloom FE.
    Neuroendocrinology; 1994 Mar; 59(3):208-17. PubMed ID: 8159270
    [Abstract] [Full Text] [Related]

  • 5. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response.
    Raber J, Koob GF, Bloom FE.
    Neurochem Int; 1997 Mar; 30(4-5):455-63. PubMed ID: 9106261
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
    Tilders FJ, Berkenbosch F, Vermes I, Linton EA, Smelik PG.
    Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A, Bugajski J.
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [Abstract] [Full Text] [Related]

  • 10. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 11. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
    Karanth S, Lyson K, McCann SM.
    Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3383-7. PubMed ID: 8475085
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus.
    Hsieh CH, Li HY, Chen JC.
    Neuroscience; 2010 Feb 17; 165(4):1191-202. PubMed ID: 20004705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine.
    Chen XQ, Du JZ, Wang YS.
    Regul Pept; 2004 Jul 15; 119(3):221-8. PubMed ID: 15120484
    [Abstract] [Full Text] [Related]

  • 15. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation.
    Raber J, Bloom FE.
    Neuroscience; 1996 Apr 15; 71(3):747-59. PubMed ID: 8867047
    [Abstract] [Full Text] [Related]

  • 16. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA, Biscardi R, Smith MD, Wilson SP.
    J Pharmacol Exp Ther; 1996 Sep 15; 278(3):1073-82. PubMed ID: 8819488
    [Abstract] [Full Text] [Related]

  • 17. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.
    Tsagarakis S, Holly JM, Rees LH, Besser GM, Grossman A.
    Endocrinology; 1988 Oct 15; 123(4):1962-9. PubMed ID: 2970959
    [Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ.
    J Pharmacol Exp Ther; 1996 Oct 15; 279(1):351-8. PubMed ID: 8859013
    [Abstract] [Full Text] [Related]

  • 19. Norepinephrine but not epinephrine stimulates the release of corticotropin-releasing factor from in vitro superfused rat hypothalamus.
    Orliaguet G, Mélik Parsadaniantz S, Lenoir V, Duval P, Kerdelhué B.
    J Neurosci Res; 1995 Oct 01; 42(2):236-41. PubMed ID: 8568924
    [Abstract] [Full Text] [Related]

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 01; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.